RT Journal Article
SR Electronic
A1 Canavan, Neil
T1 Gliptin Wars
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 7
SP 24
OP 26
DO 10.1177/155989770800800711
UL http://mdc.sagepub.com/content/8/7/24.abstract
AB Following closely behind vildagliptin and sitagliptin, the two currently marketed compounds in the DPP-IV inhibitor drug class, are the pipeline agents saxagliptin and alogliptin. This article discusses data concerning all four molecules.